




	
	  if (document.domain != 'www.netvibes.com') {	  
		  document.write(
'\n\t\n<style>\ndiv.vbp-widget * {\n    margin: 0;\n    padding: 0;\n    line-height:normal;\n    border:none;\n    text-transform:none;\n    \n}\n\ndiv.vbp-widget {\n    border: 1px solid #CCC;\n    color: #222;\n    margin: 0 auto;\n    background: #EEE;\n    font-family: \'Helvetica Neue\', Arial, sans-serif;\n    font-size: 12px;\n}\n\ndiv.vbp-widget a,\ndiv.vbp-widget a:link,\ndiv.vbp-widget a:visited {\n    text-decoration: none;\n    color: #35D;\n}\ndiv.vbp-widget a:hover {\n    text-decoration: underline;\n} \n\n/**** header ****/\n\ndiv.vbp-widget .vbp-header {\n    background: #DDD;\n    height: 44px;\n    border-bottom: 1px solid #BBB;\n    background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x top left;\n    padding: 5px 15px;\n}\n\ndiv.vbp-widget p.vbp-company {\n    padding-top: 3px;\n    margin-right: 140px;\n    float: left;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-company a {\n}\ndiv.vbp-widget .vbp-company a * {\n    display: block;\n}\n\ndiv.vbp-widget .vbp-company a strong {\n    font-size: 18px;\n    color: #333;\n    text-shadow: 0 2px 1px #FFF;\n    font-weight: bold;\n}\ndiv.vbp-widget .vbp-company a em {\n    font-style: normal;\n    font-size: 11px;\n    color: #346;\n}\n\ndiv.vbp-widget a img {\n    border: none;\n}\n\ndiv.vbp-widget .vbp-header img, div.vbp-widget .vbp-header a img {\n    float: right;\n    border: 1px solid #CCC;\n}\n\ndiv.vbp-widget p.vbp-utility {\n    width: 120px;\n    float: right;\n    padding-bottom:0;\n}\n\ndiv.vbp-widget .vbp-utility a {\n    display: block;\n    padding: 2px 5px;\n    font-size: 11px;\n    -moz-border-radius: 3px;\n\t-webkit-border-radius: 3px;\n    margin-right: 5px;\n    margin-bottom: 3px;\n}\ndiv.vbp-widget .vbp-utility a:link,\ndiv.vbp-widget .vbp-utility a:visited {\n    background: rgba(0,0,0,.08);\n    color: #111;\n    text-shadow: 0 1px 1px hsla(0,0%,100%,1);\n}\ndiv.vbp-widget .vbp-utility a:hover {\n    background: #459;\n    color: #FFF;\n    text-decoration: none;\n    text-shadow: none;\n}\n\n/**** content ****/\n\ndiv.vbp-widget div.vbp-content {\n    padding: 8px 0;\nbackground-color:#fff;\n}\n\ndiv.vbp-widget .vbp-col {\n    width: 46%;\n    float: left;\n    margin: 0 2%;\n}\n\ndiv.vbp-widget div.vbp-content p,\ndiv.vbp-widget div.vbp-content h5 {\n    padding-left: 5px;\n}\n\ndiv.vbp-widget p {\n\tmargin-top: 0px;\n  font-size: 12px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-categogy {\n    clear: both;\n    margin-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content h5 {\n    font-size: 12.5px;\n    background: #F4F4F4;\n    color: #444;\n    padding-top: 2px;\n    padding-bottom: 2px;\n    background: #F4F4F4 url(http://venturebeatprofiles.com/images/widget_heading_bg.gif) repeat-x left bottom;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p {\n    border-top: 1px dotted #E4E4E4;\n    padding-top: 4px;\n    padding-bottom: 4px;\n    margin:0;\n}\n\ndiv.vbp-widget div.vbp-content div.vbp-category p strong {\n    font-size: 11px;\n    text-transform: uppercase;\n    color: #88A;\n}\n\ndiv.vbp-widget div.vbp-content a:link,\ndiv.vbp-widget div.vbp-content a:visited {\n    color: #35D;\n}\ndiv.vbp-widget div.vbp-content a:hover {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-description, div.vbp-widget p.vbp-description-long, div.vbp-widget p.vbp-description-short {\n    padding-top: 2px;\n    padding-bottom: 8px;\n}\n\ndiv.vbp-widget .vbp-description img, div.vbp-widget .vbp-description-long img div.vbp-widget .vbp-description-short img {\n    float: left;\n    border: 1px solid #CCC;\n    margin: 0 8px 8px 0;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news {\n    margin-bottom: 0;\n    padding-bottom: 10px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p {\n    padding-top: 4px;\n    padding-bottom: 4px;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a {\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a * { display: block; }\n\ndiv.vbp-widget div.vbp-content .vbp-news p a em {\n    font-size: 10px;\n    text-transform: uppercase;\n    font-style: normal;   \n    color: #666;\n    letter-spacing: 0.08em;\n}\n\ndiv.vbp-widget div.vbp-content .vbp-news p a strong {\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover {\n    text-decoration: none;\n}\ndiv.vbp-widget div.vbp-content .vbp-news p a:hover * {\n    color: #000;\n}\n\ndiv.vbp-widget p.vbp-footer {\n    border-top: 1px solid #CCC;\n    padding: 5px 10px;\n    color: #888;\n    height: 15px;\n    font-size: 11px;\n    text-shadow: 0 1px 1px #FFF;\n}\n\ndiv.vbp-widget .vbp-footer a {\n}\n\ndiv.vbp-widget .vbp-header,\ndiv.vbp-widget .vbp-footer {\n  background: #DDD url(http://venturebeatprofiles.com/images/widget_bg.gif) repeat-x left top;\n}\n\n/**** clearfix ****/\n\n.clearfix:after {\n  content: \'\';\n  display: block;\n  height: 0;\n  clear: both;\n  visibility: hidden;\n }\n\n.tradevibes_hidden, .vbp-hide {\n\tdisplay:none !important;\n}\n</style>\n\n\n\n\n<script type="text/javascript">\n\tvar tv_long_cls = \'vbp-description-long\';\n\tvar tv_short_cls = \'vbp-description-short\';\n\tvar tv_hid = \'vbp-hide tradevibes_hidden\';\n\tfunction tradevibes_toggle_description(e) {\n\t\tvar targ;\n\t\tif (!e) var e = window.event;\n\t\tif (e.target) targ = e.target;\n\t\telse if (e.srcElement) targ = e.srcElement;\n\t\tif (targ.nodeType == 3) // defeat Safari bug\n\t\t\ttarg = targ.parentNode;\n\n\t\tvar parent = targ.parentNode;\n\t\tif (parent.className.indexOf(tv_short_cls) != -1) {\n\t\t\t// short description is visible\n\t\t\tparent.className = tv_hid + \' \' + tv_short_cls;\n\t\t\tvar sibling = parent.nextSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.nextSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_long_cls;\n\t\t}  else {\n\t\t\tparent.className = tv_hid + \' \' + tv_long_cls;\n\t\t\tvar sibling = parent.previousSibling;\n\t\t\tif (sibling.nodeType == 3) {\n\t\t\t\tsibling = sibling.previousSibling;\n\t\t\t}\n\t\t\tsibling.className = tv_short_cls;\n\t\t}\n\t}\n</script>\n\n\n<div class="vbp-widget" id="ekos" title="Ekos">\n\t<div class="vbp-header">\n\n\t\t<a class="tradevibes_logo vbp-logo " href="http://venturebeatprofiles.com/company/profile/ekos?src=widget" title="Ekos">\n\t<img src="http://venturebeatprofiles.com/ugenimage/logo/company_8372/27718.png" alt="Ekos" title="Ekos" width="80" height="40">\n</a>\n\n\n\t\t<p class="vbp-company">\n\t\t\t<a href="http://venturebeatprofiles.com/company/profile/ekos?src=widget"><strong>Ekos</strong></a>\n\t\t\t<a href="http://www.ekoscorp.com/" target="_blank"><em>http://www.ekoscorp.com/</em></a>\n\t\t</p>\n\t\t<p class="vbp-utility">\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/account/profile/add_watch/ekos?src=widget">Watch Company</a>\n\t\t\t<a target="_blank" href="http://venturebeatprofiles.com/company/widget/preview/ekos?src=widget">Get Widget</a>\n\t\t</p>\n\t</div><!-- header -->\n\t<div class="vbp-content clearfix">\n\t\t<div class="vbp-left-col vbp-col">\n\n\t\t\t<p class="vbp-description vbp-description-short tradevibes_short_description">EKOS \xae Corporation pioneered the development and the clinical application of microsonic technologies in medicine, introducing its first system for the treatment of vascular thrombosis in 2005. Today,...<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">More&raquo;</a></p>\n\t\t\t<p class="vbp-description vbp-description-long vbp-hide tradevibes_hidden">EKOS \xae Corporation pioneered the development and the clinical application of microsonic technologies in medicine, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions across the nation use EKOS MicroSonic\u2122 Accelerated Thrombolysis to provide safer, faster and more complete dissolution of thrombus. In 2008, the company introduced its 2nd generation EkoSonic\u2122 Endovascular System with Rapid Pulse\u2122 Modulation. The EkoSonic System is FDA cleared for controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature. It is currently used to treat patients with peripheral arterial occlusions (PAO) and deep vein thrombosis (DVT) and additional applications are being investigated.<a class="vbp-toggle-more tradevibes_toggle_button discovery_interesting" onclick="tradevibes_toggle_description(event);">&laquo;Less</a></p>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Overview</h5>\n\t\t\t\t<p><strong>Location:</strong> \tBothell, WA, United States\n</p>\n\t\t\t\t<p><strong>Industry:</strong> Medical Devices &amp; Equipment</p>\n\t\t\t\t<p><strong>Employees:</strong> 145</p>\n\t\t\t\t<p><strong>Tags:</strong>\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=development">development</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=corporation">corporation</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=2005">2005</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=system">system</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=clinical">clinical</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=treatment">treatment</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=radiologists">radiologists</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=vascular">vascular</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=medicine">medicine</a>,\n\t\t\t\t<a href="http://venturebeatprofiles.com/company/tag_list?tag=technologies">technologies</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Financials</h5>\n\t\t\t\t<p><strong>Latest Funding:</strong> Series D - $12.5M (01/2009)</p>\n\t\t\t\t<p><strong>Investors:</strong>\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/crown-venture-fund?src=widget">Crown Venture Fund</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/ascension-health-ventures?src=widget">Ascension Health Ventures</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/cid-capital?src=widget">CID Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/eds-healthcare-capital-partners?src=widget">EDS Healthcare Capital Partners</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/medventure-associates?src=widget">MedVenture Associates</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/mitsui-co-venture-partners?src=widget">Mitsui &amp; Co. Venture Partners</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/ngn-capital?src=widget">NGN Capital</a>,\n\t\t\t\t\t\n\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/investor/profile/protostar-equity-partners?src=widget">Protostar Equity Partners</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\t\t</div><!-- col -->\n\t\t<div class="vbp-right-col vbp-col">\n\t\t\t<div class="vbp-category">\n\t\t\t\t<h5>Market</h5>\n\t\t\t\t<p><strong>Competitors:</strong>\n\t\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/usgi-medical?src=widget">USGI Medical</a>\n\t\t\t\t</p>\n\n\t\t\t\t<p><strong>Related Companies:</strong>\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/applied-spine-technologies?src=widget">Applied Spine Technologies</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/usgi-medical?src=widget">USGI Medical</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/infinity-pharmaceuticals?src=widget">Infinity Pharmaceuticals</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/homestead-clinical?src=widget">Homestead Clinical</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/cardiva-medical?src=widget">Cardiva Medical</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/neurobiological-technologies?src=widget">Neurobiological Technologies</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/cayenne-medical?src=widget">Cayenne Medical</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/accelerator?src=widget">Accelerator</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/lentigen?src=widget">Lentigen</a>,\n\t\t\t\t\t<a class="discovery_interesting" href="http://venturebeatprofiles.com/company/profile/insite-vision?src=widget">InSite Vision</a>\n\t\t\t\t</p>\n\t\t\t</div>\n\n\t\t\t<div class="vbp-news">\n\t\t\t\t<h5>Recent News</h5>\n\t\t\t\t<p><a href="http://venturebeatprofiles.com/news/view/ekos?article=90651">\n\t\t\t\t\t<em>Jan 30, 2009</em>\n\t\t\t\t\t<strong>Report: Ekos Gets $12.5M</strong>\n\t\t\t\t</a></p>\n\t\t\t</div>\n\n\t\t</div><!-- col -->\n\t</div><!-- content -->\n\t<p class="vbp-footer">\n\t\t<a href="http://venturebeatprofiles.com/company/profile/ekos?src=widget">Ekos Company Profile</a> powered by <a href="http://venturebeatprofiles.com/?src=widget">VentureBeat Profiles</a>.\n\t</p>\n</div><!-- widget -->\n'
);
		  if (typeof tradevibes_post == "function") {
			  tradevibes_post();
		  }
	  }






